Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EDGEWELL PERSONAL CARE CoEPC · Entity 4787 | Chief People & Legal Officer | November 13, 2025 | November 17, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EDGEWELL PERSONAL CARE Co
Report date November 13, 2025 · Filed November 17, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,667 |
Ending reported balance
After 2025-11-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-11-13 · Exercise / conversion · Acquired 5,773 · Balance 22,540 Row 2 · 2025-11-13 · Tax withholding · Disposed 2,873 · Balance 19,667 F1: Shares withheld as payment of a tax liability on vesting of performance stock equivalents. |
| Performance Stock Award 11-11-2022SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2025-11-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-11-13 · Exercise / conversion · Disposed 5,773 · Balance 0 F2: Performance Stock Equivalents vested and converted into shares of EPC common stock on 11/13/2025. The original award was 16,353 shares; only 5,773 vested in accordance with the performance criteria. The remaining 10,580 shares were cancelled. |
| Restricted Stock Equivalents 11-14-2025SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 24,270 |
Reported balance
After 2025-11-14 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-11-14 · Grant · Acquired 24,270 · Balance 24,270 F3: One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/14/2026, 11/14/2027 and 11/14/2028 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld as payment of a tax liability on vesting of performance stock equivalents.
F2: Performance Stock Equivalents vested and converted into shares of EPC common stock on 11/13/2025. The original award was 16,353 shares; only 5,773 vested in accordance with the performance criteria. The remaining 10,580 shares were cancelled.
F3: One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/14/2026, 11/14/2027 and 11/14/2028 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2022 Filed Apr 5, 2022 20:34 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantNon-Qualified Stock Options 4/1/2022 · Derivative | 5,031 | $0.00 Strike: $36.77 | $0.00 |
DisclosureSEC source: 0001209191-22-023046 · doc4.xml · derivative · entry 1 Langley LaTanya · CIK 0001915754 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,031 Underlying: Common Stock · 5,031 shares Expires 2032-04-01 F1 · derivative.exercise_date: One-third of the Options will become exercisable on each of 11/12/2022, 11/12/2023 and 11/12/2024, as long as the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.